Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma

Author： Moriya Makio Yamada Tadaaki Tamura Masaya Ishikawa Daisuke Hoda Mir Alireza Matsumoto Isao Klepetko Walter Oda Makoto Yano Seiji Watanabe Go

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.31, Iss.3, 2014-03, pp. : 1109-1115

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo

By Zhu Yuanxi

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1349-1362

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic antitumor efficacy of anti-epidermal growth factor receptor antibody, cetuximab, against malignant pleural mesothelioma

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1610-1618

Spandidos Publications

Access to resources Recommend Favorite

Antitumor activity of MEK and PI3K inhibitors against malignant pleural mesothelioma cells in vitro and in vivo

International Journal of Oncology, Vol. 41, Iss. 2, 2012-01 ,pp. : 449-456

Spandidos Publications

Access to resources Recommend Favorite

Apoptosis and antitumor effects induced by the combination of an mTOR inhibitor and an autophagy inhibitor in human osteosarcoma MG63 cells

By Horie Ryosuke Nakamura Osamu Yamagami Yoshiki Mori Masaki Nishimura Hideki Fukuoka Natsuko Yamamoto Tetsuji

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 37-44

Spandidos Publications

Access to resources Recommend Favorite

Chemotherapy for Malignant Pleural Mesothelioma

By Garland Linda

Current Treatment Options in Oncology, Vol. 12, Iss. 2, 2011-06 ,pp. : 181-188

Springer Publishing Company

Access to resources Recommend Favorite